查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物活性傷口敷料市場：按產品、按屬性類型、按應用、按最終用戶、按地區 - 預測至 2029 年
市場調查報告書
商品編碼
1552970

生物活性傷口敷料市場：按產品、按屬性類型、按應用、按最終用戶、按地區 - 預測至 2029 年

Bioactive Dressings Market by Product (Collagen, Alginate, Chitosan, Skin Substitute), Property (Antimicrobial, Non-antimicrobial), Application (Chronic Wounds (Diabetic Foot, Pressure Ulcers), Acute Wounds (Surgical, Burns))- Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 344 Pages | 訂單完成後即時交付

價格

全球生物活性傷口敷料市場規模預計將從 2024 年的 35 億美元增加到 2029 年的 58 億美元，預測期內複合年成長率為 10.5%。

慢性傷口發生率上升和老年人口增加是推動生物活性傷口敷料需求的主要因素。傷口敷料技術的進步以及人們對其益處的認知不斷提高，例如更快的癒合和患者的舒適度，正在推動市場成長，持續的創新預計將進一步擴大。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（十億美元）
部分 按產品、按財產類型、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、中東/非洲、拉丁美洲、海灣合作理事會國家

按產品類型分類，生物活性傷口敷料市場分為生物活性傷口敷料和皮膚替代品。 2023年，生物活性傷口敷料產業引領市場。此細分市場的成長主要是由於慢性、外科性創傷和創傷性傷口的盛行率不斷增加、燒傷盛行率不斷增加、生物活性傷口敷料的技術進步以及慢性和外科性創傷治療支出的增加。

根據應用，生物活性傷口敷料市場分為急性傷口和慢性傷口。 2023年，慢性傷口細分市場佔最大市場佔有率。此細分市場的大部分佔有率歸因於老年人口的增加和慢性傷口發生率的上升，包括糖尿病足潰瘍、壓瘡、動脈潰瘍、靜脈性腿部潰瘍等。

按最終用戶分類，生物活性傷口敷料市場分為醫院和診所、長期照護設施、家庭護理設施等。 2023年，醫院和診所將佔據最大的市場佔有率。然而，預計家庭護理設施在預測期內將以最高的複合年成長率成長，主要是因為與醫院相比，它們具有成本效益，並且提供便利和舒適。

該報告研究了全球生物活性傷口敷料市場，包括按產品、財產類型、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 價格分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管分析
  • 貿易分析
  • 技術分析
  • 2024-2025年重大會議和活動
  • 影響客戶業務的趨勢/干擾
  • 投資金籌措場景
  • 人工智慧對生物活性傷口敷料市場的影響

第6章生物活性傷口敷料市場（依產品）

  • 介紹
  • 生物活性傷口敷料
  • 皮膚替代品

第7章生物活性傷口敷料市場（依特徵類型）

  • 介紹
  • 非抗菌傷口敷料
  • 抗菌傷口敷料

第8章生物活性傷口敷料市場（依應用）

  • 介紹
  • 慢性傷口
  • 急性傷口

第9章生物活性傷口敷料市場（按最終用戶）

  • 介紹
  • 醫院/診所
  • 居家護理設施
  • 長期照護設施
  • 其他

第10章生物活性傷口敷料市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
  • 海灣合作理事會國家

第11章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 公司評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • SMITH+NEPHEW
    • ORGANOGENESIS INC.
    • MIMEDX GROUP, INC.
    • 3M
    • CARDINAL HEALTH
    • B. BRAUN SE
    • MOLNLYCKE AB
    • CONVATEC INC.
    • PAUL HARTMANN AG
    • COLOPLAST CORP.
    • INTEGRA LIFESCIENCES CORPORATION
    • ESSITY AKTIEBOLAG
    • COVALON TECHNOLOGIES LTD.
    • SANARA MEDTECH
  • 其他公司
    • MEDLINE INDUSTRIES, INC.
    • HOLLISTER INCORPORATED
    • L&R GROUP
    • DERMARITE INDUSTRIES, LLC
    • BIOTISSUE
    • LIFENET HEALTH
    • ADVANCIS MEDICAL
    • HUMAN BIOSCIENCES
    • AMERX HEALTH CARE
    • GENTELL
    • AXIO BIOSOLUTIONS PVT. LTD.

第13章附錄

Product Code: MD 9133

The global bioactive dressings market is projected to reach USD 5.8 billion by 2029 from USD 3.5 billion in 2024, at a CAGR of 10.5% during the forecast period. The rising incidence of chronic wounds and the increasing elderly population are the major drivers boosting the demand for bioactive dressings. Technology advancements in wound dressings and increased awareness of the benefits like faster healing and patient comfort, are driving market growth, with further expansion anticipated due to ongoing innovation.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsProduct Type, Property Type, Application, End User
Regions coveredNorth America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC Countries

"Bioactive dressings segment accounted for the highest market share in the bioactive dressings market, by product type, during the forecast period."

Based on product type, the bioactive dressings market is divided into bioactive dressings and skin substitutes. In 2023, the bioactive dressings segment led the market. The growth of this segment is primarily driven by the increasing prevalence of chronic, surgical, and traumatic wounds; a rising number of burn injuries; technological advancements in bioactive dressings; and increased spending on the treatment of chronic and surgical wounds

"Chronic wound segment accounted for the highest market share in the bioactive dressings market, by application, during the forecast period."

Based on application, the bioactive dressings market is divided into acute wounds and chronic wounds. In 2023, the chronic wounds segment held the largest market share. The majority share of this segment is attributed to the increasing elderly population and the rising incidence of chronic wounds, including diabetic foot ulcers, pressure ulcers, arterial ulcers and venous leg ulcers, among others.

"Home Care Settings accounted for the highest CAGR during the forecast period."

Based on end user, the bioactive dressings market is segmented into hospitals and clinics, long-term care facilities, home care settings, and other end users. In 2023, hospitals and clinics held the largest market share. However, home care settings are projected to grow at the highest CAGR during the forecast period, mainly due to their cost-efficiency compared to hospitals, as well as the convenience and comfort they offer.

"The North America segment accounted for the highest market share in the bioactive dressings market, by region, during the forecast period."

Bioactive dressings market is divided into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), the Middle East & Africa (MEA) and GCC Countries. During the forecast period the North America is expected to witness a larger market share. The expansion of the bioactive dressings market in North America is fueled by the high prevalence of chronic wounds, advancements in bioactive dressing technologies, and increased healthcare spending.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (42%), Asia- Pacific (31%), Europe (20%), Latin America- (4%) and MEA-(2%), and GCC (1%).

Prominent companies include 3M (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Molnlycke Health Care AB (Sweden), Convatec Inc. (UK), Paul Hartmann Ag (Germany), Coloplast Corp (Denmark), Integra LifeSciences Corporation (US), Organogenesis Inc.(US), Essity(Sweden), Covalon Technologies(Canada), Mimedx Group, Inc.(US), Sanara Medtech Inc.(US), Medline Industries, LP.(US), Hollister Incorporated(US), Lohmann & Rauscher (L&R) (Germany), DermaRite Industries, LLC (US), BioTissue (US), LifeNet Health (US), Advancis Medical(UK), Human BioSciences (US), AMERX Health Care (US), Gentell (US) and Axio Biosolutions Pvt Ltd (India).

Research Coverage

This research report categorizes the bioactive dressings market by product type, property type, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioactive dressings market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the bioactive dressings market. Competitive analysis of upcoming startups in the bioactive dressings market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioactive dressings market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioactive dressings market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioactive dressings market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the bioactive dressings market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bioactive dressings market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like 3M (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Molnlycke Health Care AB (Sweden), Convatec Inc. (UK), Paul Hartmann Ag (Germany), Coloplast Corp (Denmark), Integra LifeSciences Corporation (US), Organogenesis Inc.(US), Covalon Technologies(Canada), and Mimedx Group, Inc.(US) among others in the bioactive dressings market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 BIOACTIVE DRESSINGS MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
      • 2.2.1.2 Approach 3: Presentations of companies and primary interviews
      • 2.2.1.3 Growth forecast
      • 2.2.1.4 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 STUDY ASSUMPTIONS
    • 2.4.1 GROWTH RATE ASSUMPTIONS
    • 2.4.2 LIMITATIONS
  • 2.5 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BIOACTIVE DRESSINGS MARKET OVERVIEW
  • 4.2 BIOACTIVE DRESSINGS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
  • 4.3 BIOACTIVE DRESSINGS MARKET SHARE, BY TYPE, 2024 VS. 2029
  • 4.4 SKIN SUBSTITUTES MARKET SHARE, BY TYPE, 2024 VS. 2029
  • 4.5 BIOACTIVE DRESSINGS MARKET SHARE, BY PROPERTY TYPE, 2024 VS. 2029
  • 4.6 BIOACTIVE DRESSINGS MARKET SHARE, BY APPLICATION, 2024 VS. 2029
  • 4.7 BIOACTIVE DRESSINGS MARKET SHARE FOR CHRONIC WOUNDS, BY TYPE, 2024 VS. 2029
  • 4.8 BIOACTIVE DRESSINGS MARKET SHARE FOR ACUTE WOUNDS, BY TYPE, 2024 VS. 2029
  • 4.9 BIOACTIVE DRESSINGS MARKET SHARE, BY END USER, 2024 VS. 2029
  • 4.10 BIOACTIVE DRESSINGS MARKET SHARE FOR HOSPITALS & CLINICS, BY TYPE, 2024 VS. 2029
  • 4.11 BIOACTIVE DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of chronic wounds
      • 5.2.1.2 Growing geriatric population
      • 5.2.1.3 Increasing number of surgical procedures worldwide
      • 5.2.1.4 Increasing incidence of burn injuries
      • 5.2.1.5 Advancements in bioactive dressing technology
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs of bioactive dressing products
      • 5.2.2.2 Limited reimbursement policies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential of emerging countries
      • 5.2.3.2 New product development
      • 5.2.3.3 Strategic collaboration between market players
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Difficult regulatory approval process
      • 5.2.4.2 Lack of awareness and education
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS
    • 5.3.2 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 BIOACTIVE DRESSINGS MARKET: ROLE IN ECOSYSTEM
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 DEGREE OF COMPETITION
  • 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.9.2 BUYING CRITERIA
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATORY LANDSCAPE
      • 5.10.1.1 North America
        • 5.10.1.1.1 US
        • 5.10.1.1.2 Canada
      • 5.10.1.2 Europe
      • 5.10.1.3 Asia Pacific
        • 5.10.1.3.1 China
        • 5.10.1.3.2 Japan
        • 5.10.1.3.3 India
      • 5.10.1.4 Latin America
        • 5.10.1.4.1 Brazil
        • 5.10.1.4.2 Mexico
      • 5.10.1.5 Middle East
      • 5.10.1.6 Africa
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES
  • 5.12 TECHNOLOGY ANALYSIS
    • 5.12.1 KEY TECHNOLOGIES
      • 5.12.1.1 Kollagen technology
    • 5.12.2 COMPLEMENTARY TECHNOLOGIES
      • 5.12.2.1 Bioactive microfiber gelling technology
    • 5.12.3 ADJACENT TECHNOLOGIES
      • 5.12.3.1 Kerecis intact fish skin technology
  • 5.13 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI ON BIOACTIVE DRESSINGS MARKET

6 BIOACTIVE DRESSINGS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 BIOACTIVE DRESSINGS
    • 6.2.1 COLLAGEN DRESSINGS
      • 6.2.1.1 Unique healing properties and biocompatibility to drive growth
    • 6.2.2 ALGINATE DRESSINGS
      • 6.2.2.1 Excellent absorption capacity to boost demand for alginate dressings
    • 6.2.3 CHITOSAN DRESSINGS
      • 6.2.3.1 Rising need for effective, natural wound healing options to support market growth
    • 6.2.4 HONEY DRESSINGS
      • 6.2.4.1 Effective and natural wound care management to fuel growth
    • 6.2.5 OTHER BIOACTIVE DRESSINGS
  • 6.3 SKIN SUBSTITUTES
    • 6.3.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS
      • 6.3.1.1 High efficacy of human donor tissue-derived products to support market demand
    • 6.3.2 ACELLULAR ANIMAL-DERIVED PRODUCTS
      • 6.3.2.1 Recognition of importance of ECM in wound treatment to boost development of acellular wound care biologics
    • 6.3.3 BIOSYNTHETIC PRODUCTS
      • 6.3.3.1 Increased bioburden of infected wounds to stimulate market growth

7 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE

  • 7.1 INTRODUCTION
  • 7.2 NON-ANTIMICROBIAL DRESSINGS
    • 7.2.1 COST-EFFECTIVENESS COMPARED TO ANTIMICROBIAL DRESSINGS TO BOOST MARKET
  • 7.3 ANTIMICROBIAL DRESSINGS
    • 7.3.1 EFFECTIVENESS IN PREVENTING AND MANAGING INFECTIONS TO DRIVE GROWTH

8 BIOACTIVE DRESSINGS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 CHRONIC WOUNDS
    • 8.2.1 DIABETIC FOOT ULCERS
      • 8.2.1.1 Increasing prevalence of diabetes to drive growth
    • 8.2.2 PRESSURE ULCERS
      • 8.2.2.1 Growing geriatric population to drive demand for bioactive dressings
    • 8.2.3 VENOUS LEG ULCERS
      • 8.2.3.1 Rising prevalence of obesity to boost adoption
    • 8.2.4 OTHER CHRONIC WOUNDS
  • 8.3 ACUTE WOUNDS
    • 8.3.1 SURGICAL WOUNDS
      • 8.3.1.1 Rising volume of surgical procedures to support market growth
    • 8.3.2 TRAUMATIC WOUNDS
      • 8.3.2.1 Increasing number of road accidents to drive growth
    • 8.3.3 BURNS
      • 8.3.3.1 High incidence of burn injuries to propel market growth

9 BIOACTIVE DRESSINGS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & CLINICS
    • 9.2.1 INPATIENT SETTINGS
      • 9.2.1.1 Increasing hospital admissions due to HAIs to drive growth
    • 9.2.2 OUTPATIENT SETTINGS
      • 9.2.2.1 Rising costs of inpatient facilities to drive demand for outpatient care settings
  • 9.3 HOME CARE SETTINGS
    • 9.3.1 LOW COSTS AND CONVENIENCE TO DRIVE GROWTH
  • 9.4 LONG-TERM CARE FACILITIES
    • 9.4.1 GROWTH IN GERIATRIC & VULNERABLE POPULATIONS TO BOOST DEMAND FOR BETTER LONG-TERM CARE
  • 9.5 OTHER END USERS

10 BIOACTIVE DRESSINGS MARKET, BY REGION

  • 10.1 INTRODUCTIONS
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Rising prevalence of chronic diseases to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Growing awareness about diabetes and its associated complications to fuel market
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising focus on medical technology clusters to boost market
    • 10.3.2 UK
      • 10.3.2.1 Increasing prevalence of surgeries to aid growth
    • 10.3.3 FRANCE
      • 10.3.3.1 Surge in elderly population to propel market
    • 10.3.4 ITALY
      • 10.3.4.1 Improved life expectancy to support growth
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing median age to augment growth
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Growing incidence of diabetic foot ulceration to drive market
    • 10.4.2 JAPAN
      • 10.4.2.1 Expanding hospital infrastructure to fuel market
    • 10.4.3 INDIA
      • 10.4.3.1 Booming medical tourism in India to boost market
    • 10.4.4 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 Presence of large patient population to stimulate growth
    • 10.5.2 MEXICO
      • 10.5.2.1 Growing awareness about effective wound care approaches to support growth
    • 10.5.3 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO AID MARKET GROWTH
  • 10.7 GCC COUNTRIES
    • 10.7.1 FAVORABLE HEALTHCARE INFRASTRUCTURE AND INITIATIVES TO BOOST MARKET

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Product footprint
      • 11.5.5.3 Property footprint
      • 11.5.5.4 Application footprint
      • 11.5.5.5 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 SMITH+NEPHEW
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Expansions
        • 12.1.1.3.2 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 ORGANOGENESIS INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product approvals
        • 12.1.2.3.2 Other developments
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 MIMEDX GROUP, INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches and approvals
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 3M
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Other developments
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 CARDINAL HEALTH
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 MnM view
        • 12.1.5.3.1 Key strengths
        • 12.1.5.3.2 Strategic choices
        • 12.1.5.3.3 Weaknesses and competitive threats
    • 12.1.6 B. BRAUN SE
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
    • 12.1.7 MOLNLYCKE AB
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
    • 12.1.8 CONVATEC INC.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product approvals
        • 12.1.8.3.2 Deals
    • 12.1.9 PAUL HARTMANN AG
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 COLOPLAST CORP.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Deals
    • 12.1.11 INTEGRA LIFESCIENCES CORPORATION
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Deals
    • 12.1.12 ESSITY AKTIEBOLAG
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product launches
        • 12.1.12.3.2 Deals
    • 12.1.13 COVALON TECHNOLOGIES LTD.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Other developments
    • 12.1.14 SANARA MEDTECH
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Product launches
        • 12.1.14.3.2 Deals
  • 12.2 OTHER PLAYERS
    • 12.2.1 MEDLINE INDUSTRIES, INC.
    • 12.2.2 HOLLISTER INCORPORATED
    • 12.2.3 L&R GROUP
    • 12.2.4 DERMARITE INDUSTRIES, LLC
    • 12.2.5 BIOTISSUE
    • 12.2.6 LIFENET HEALTH
    • 12.2.7 ADVANCIS MEDICAL
    • 12.2.8 HUMAN BIOSCIENCES
    • 12.2.9 AMERX HEALTH CARE
    • 12.2.10 GENTELL
    • 12.2.11 AXIO BIOSOLUTIONS PVT. LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 RISK ASSESSMENT ANALYSIS
  • TABLE 2 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
  • TABLE 3 BIOACTIVE DRESSINGS MARKET: RECENT PRODUCT LAUNCHES
  • TABLE 4 BIOACTIVE DRESSINGS MARKET: RECENT COLLABORATIONS OF NOTE
  • TABLE 5 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS, BY PRODUCT, 2021-2023
  • TABLE 6 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION (2023)
  • TABLE 7 BIOACTIVE DRESSINGS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS (%)
  • TABLE 9 KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 IMPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 15 EXPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 16 BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 17 BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 18 BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 19 BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 20 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 21 EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 KEY PRODUCTS IN COLLAGEN DRESSINGS SEGMENT
  • TABLE 25 COLLAGEN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 26 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 KEY PRODUCTS IN ALGINATE DRESSINGS SEGMENT
  • TABLE 31 ALGINATE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 KEY PRODUCTS IN CHITOSAN DRESSINGS SEGMENT
  • TABLE 37 CHITOSAN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 EUROPE: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 LATIN AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 KEY PRODUCTS IN HONEY DRESSINGS SEGMENT
  • TABLE 43 HONEY DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 OTHER BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 NORTH AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 EUROPE: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 LATIN AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 KEY PRODUCTS IN SKIN SUBSTITUTES SEGMENT
  • TABLE 54 SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 55 SKIN SUBSTITUTES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 EUROPE: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS SEGMENT
  • TABLE 61 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS SEGMENT
  • TABLE 67 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 EUROPE: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 KEY PRODUCTS IN NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET
  • TABLE 79 NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 EUROPE: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 KEY PRODUCTS IN ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET
  • TABLE 85 ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 91 BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021
  • TABLE 98 NUMBER OF PATIENTS DEVELOPING NEW CASES OF DIABETIC FOOT ULCERS, 2022-2029 (THOUSAND)
  • TABLE 99 BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 EUROPE: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 EUROPE: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 EUROPE: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 BIOACTIVE DRESSINGS MARKET FOR BURNS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 EUROPE: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 141 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2022
  • TABLE 142 BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 EUROPE: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 164 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 EUROPE: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 169 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 183 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 US: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 US: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 US: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 US: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 US: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 189 US: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 US: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 US: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 192 US: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 DIABETES INCIDENCE IN CANADA, 2023 VS. 2032
  • TABLE 194 CANADA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 195 CANADA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 CANADA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 CANADA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 CANADA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 199 CANADA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 CANADA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 CANADA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 202 CANADA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
  • TABLE 204 PREVALENCE OF DIABETES IN EUROPE, 2021 VS. 2045
  • TABLE 205 EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 207 EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 211 EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 214 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 GERMANY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 216 GERMANY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 GERMANY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 GERMANY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 GERMANY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 220 GERMANY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 GERMANY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 GERMANY: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 223 GERMANY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 UK: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 225 UK: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 UK: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 UK: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 UK: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 229 UK: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 UK: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 UK: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 232 UK: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 FRANCE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 234 FRANCE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 FRANCE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 FRANCE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 237 FRANCE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 238 FRANCE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 FRANCE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 FRANCE: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 241 FRANCE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 ITALY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 243 ITALY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 ITALY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 ITALY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 ITALY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 247 ITALY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 ITALY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 ITALY: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 250 ITALY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 SPAIN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 252 SPAIN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 SPAIN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 SPAIN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 SPAIN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 256 SPAIN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 SPAIN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 SPAIN: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 259 SPAIN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 261 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 REST OF EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 265 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 CHINA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 280 CHINA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 CHINA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 CHINA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 CHINA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 284 CHINA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 CHINA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 CHINA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 287 CHINA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 JAPAN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 289 JAPAN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 JAPAN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 JAPAN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 JAPAN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 293 JAPAN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 JAPAN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 JAPAN: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 296 JAPAN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 297 INDIA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 298 INDIA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 INDIA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION)
  • TABLE 300 INDIA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 INDIA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 302 INDIA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 303 INDIA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 INDIA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 305 INDIA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 307 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION),
  • TABLE 308 REST OF ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 316 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 317 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 LATIN AMERICA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 321 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 323 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 326 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 BRAZIL: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 330 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 331 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 332 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 333 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 MEXICO: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 335 MEXICO: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 MEXICO: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 MEXICO: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 MEXICO: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 339 MEXICO: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 340 MEXICO: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 MEXICO: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 342 MEXICO: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 346 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 347 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 348 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 351 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 DIABETES IN MIDDLE EAST & NORTH AFRICA, 2021
  • TABLE 353 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 358 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 GCC COUNTRIES: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 365 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
  • TABLE 366 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 368 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BIOACTIVE DRESSINGS MARKET
  • TABLE 372 BIOACTIVE DRESSINGS MARKET: DEGREE OF COMPETITION
  • TABLE 373 BIOACTIVE DRESSINGS MARKET RANKING, BY KEY PLAYER, 2023
  • TABLE 374 GLOBAL SKIN SUBSTITUTES MARKET RANKING, BY KEY PLAYER, 2023
  • TABLE 375 BIOACTIVE DRESSINGS MARKET: PRODUCT FOOTPRINT
  • TABLE 376 BIOACTIVE DRESSINGS MARKET: PROPERTY FOOTPRINT
  • TABLE 377 BIOACTIVE DRESSINGS MARKET: APPLICATION FOOTPRINT
  • TABLE 378 BIOACTIVE DRESSINGS MARKET: REGION FOOTPRINT
  • TABLE 379 BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 380 BIOACTIVE DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 381 BIOACTIVE DRESSINGS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 382 BIOACTIVE DRESSINGS MARKET: DEALS, JANUARY 2021-JULY 2024
  • TABLE 383 BIOACTIVE DRESSINGS MARKET: EXPANSIONS, JANUARY 2021-JULY 2024
  • TABLE 384 BIOACTIVE DRESSINGS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 385 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 386 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 387 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-JULY 2024
  • TABLE 388 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 389 ORGANOGENESIS INC.: COMPANY OVERVIEW
  • TABLE 390 ORGANOGENESIS INC.: PRODUCTS OFFERED
  • TABLE 391 ORGANOGENESIS INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 392 ORGANOGENESIS INC.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 393 MIMEDX GROUP, INC.: COMPANY OVERVIEW
  • TABLE 394 MIMEDX GROUP, INC.: PRODUCTS OFFERED
  • TABLE 395 MIMEDX GROUP, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 396 MIMEDX GROUP, INC.: DEALS, JANUARY 2021-JULY 2024
  • TABLE 397 3M: COMPANY OVERVIEW
  • TABLE 398 3M: PRODUCTS OFFERED
  • TABLE 399 3M: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 400 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 401 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 402 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 403 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 404 MOLNLYCKE AB: COMPANY OVERVIEW
  • TABLE 405 MOLNLYCKE AB: PRODUCTS OFFERED
  • TABLE 406 CONVATEC INC.: COMPANY OVERVIEW
  • TABLE 407 CONVATEC INC.: PRODUCTS OFFERED
  • TABLE 408 CONVATEC INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 409 CONVATEC INC.: DEALS, JANUARY 2021-JULY 2024
  • TABLE 410 PAUL HARTMANN AG: COMPANY OVERVIEW
  • TABLE 411 PAUL HARTMANN AG: PRODUCTS OFFERED
  • TABLE 412 COLOPLAST CORP.: COMPANY OVERVIEW
  • TABLE 413 COLOPLAST CORP.: PRODUCTS OFFERED
  • TABLE 414 COLOPLAST CORP.: DEALS, JANUARY 2021-JULY 2024
  • TABLE 415 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 416 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 417 INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021-JULY 2024
  • TABLE 418 ESSITY AKTIEBOLAG: COMPANY OVERVIEW
  • TABLE 419 ESSITY AKTIEBOLAG: PRODUCTS OFFERED
  • TABLE 420 ESSITY AKTIEBOLAG: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024
  • TABLE 421 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021-JULY 2024
  • TABLE 422 COVALON TECHNOLOGIES LTD.: COMPANY OVERVIEW
  • TABLE 423 COVALON TECHNOLOGIES LTD.: PRODUCTS OFFERED
  • TABLE 424 COVALON TECHNOLOGIES LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 425 SANARA MEDTECH: COMPANY OVERVIEW
  • TABLE 426 SANARA MEDTECH: PRODUCTS OFFERED
  • TABLE 427 SANARA MEDTECH: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024
  • TABLE 428 SANARA MEDTECH: DEALS, JANUARY 2021-JULY 2024
  • TABLE 429 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 430 HOLLISTER INCORPORATED: COMPANY OVERVIEW
  • TABLE 431 L&R GROUP: COMPANY OVERVIEW
  • TABLE 432 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW
  • TABLE 433 BIOTISSUE: COMPANY OVERVIEW
  • TABLE 434 LIFENET HEALTH: COMPANY OVERVIEW
  • TABLE 435 ADVANCIS MEDICAL: COMPANY OVERVIEW
  • TABLE 436 HUMAN BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 437 AMERX HEALTH CARE: COMPANY OVERVIEW
  • TABLE 438 GENTELL: COMPANY OVERVIEW
  • TABLE 439 AXIO BIOSOLUTIONS PVT. LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS COVERED
  • FIGURE 2 RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 BIOACTIVE DRESSINGS MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 BIOACTIVE DRESSINGS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 BIOACTIVE DRESSINGS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GROWING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • FIGURE 15 SKIN SUBSTITUTES SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 16 COLLAGEN DRESSINGS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 17 HUMAN DONOR TISSUE-DERIVED PRODUCTS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 NON-ANTIMICROBIAL DRESSINGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 19 CHRONIC WOUNDS SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 20 DIABETIC FOOT ULCERS SEGMENT TO LEAD MARKET IN 2029
  • FIGURE 21 SURGICAL WOUNDS SEGMENT TO LEAD MARKET IN 2029
  • FIGURE 22 HOSPITALS & CLINICS SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 23 INPATIENT SETTINGS SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 24 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BIOACTIVE DRESSINGS MARKET DURING FORECAST PERIOD
  • FIGURE 25 BIOACTIVE DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 PATENT ANALYSIS FOR BIOACTIVE DRESSING PRODUCTS (JANUARY 2014-DECEMBER 2023)
  • FIGURE 27 BIOACTIVE DRESSINGS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 BIOACTIVE DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 BIOACTIVE DRESSINGS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 BIOACTIVE DRESSINGS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS
  • FIGURE 32 KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS
  • FIGURE 33 REVENUE SHIFT IN BIOACTIVE DRESSINGS MARKET
  • FIGURE 34 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET (2021-2023)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET (2023)
  • FIGURE 38 BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 BIOACTIVE DRESSINGS MARKET: COMPANY FOOTPRINT
  • FIGURE 40 BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 BIOACTIVE DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 47 3M: COMPANY SNAPSHOT (2023)
  • FIGURE 48 CARDINAL HEALTH: COMPANY SNAPSHOT (2023)
  • FIGURE 49 B. BRAUN SE: COMPANY SNAPSHOT (2023)
  • FIGURE 50 MOLNLYCKE AB: COMPANY SNAPSHOT (2023)
  • FIGURE 51 CONVATEC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023)
  • FIGURE 53 COLOPLAST CORP.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2023)
  • FIGURE 56 COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 SANARA MEDTECH: COMPANY SNAPSHOT (2023)